Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down0.11% Nasdaq Down0.17%

Pacific Biosciences of California, Inc. (PACB)

-NasdaqGS

2.79 Down 0.01(0.36%) 1:15PM EDT - Nasdaq Real Time Price

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Total Revenue 25,983   33,863   1,674  
Cost of Revenue25,043  20,829   -  
Gross Profit 940   13,034   1,674  
Operating Expenses
Research Development47,623  76,080  111,821  
Selling General and Administrative47,655  46,710  30,087  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (94,338) (109,756) (140,234)
Income from Continuing Operations
Total Other Income/Expenses Net(127)368  68  
Earnings Before Interest And Taxes(94,465)(109,388)(140,166)
Interest Expense -   -   -  
Income Before Tax(94,465)(109,388)(140,166)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(94,465)(109,388)(140,166)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (94,465) (109,388) (140,166)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (94,465) (109,388) (140,166)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.